These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
235 related items for PubMed ID: 14613639
21. Phospho-Stat3 expression and correlation with VEGF, p53, and Bcl-2 in gastric carcinoma using tissue microarray. Choi JH, Ahn MJ, Park CK, Han HX, Kwon SJ, Lee YY, Kim IS. APMIS; 2006 Sep; 114(9):619-25. PubMed ID: 16948814 [Abstract] [Full Text] [Related]
22. Analysis of signal transducer and activator of transcription 3 (Stat 3) pathway in multiple myeloma: Stat 3 activation and cyclin D1 dysregulation are mutually exclusive events. Quintanilla-Martinez L, Kremer M, Specht K, Calzada-Wack J, Nathrath M, Schaich R, Höfler H, Fend F. Am J Pathol; 2003 May; 162(5):1449-61. PubMed ID: 12707028 [Abstract] [Full Text] [Related]
23. [Effects of acitretin on the expression of signaling pathway-related genes in epidermal squamous-cell carcinoma cells]. Cai SQ, Chen LR, Zheng M. Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):21-4. PubMed ID: 16737614 [Abstract] [Full Text] [Related]
24. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3. Leslie K, Lang C, Devgan G, Azare J, Berishaj M, Gerald W, Kim YB, Paz K, Darnell JE, Albanese C, Sakamaki T, Pestell R, Bromberg J. Cancer Res; 2006 Mar 01; 66(5):2544-52. PubMed ID: 16510571 [Abstract] [Full Text] [Related]
28. Signal transducers and activators of transcription 3 activation is involved in nuclear accumulation of beta-catenin in colorectal cancer. Kawada M, Seno H, Uenoyama Y, Sawabu T, Kanda N, Fukui H, Shimahara Y, Chiba T. Cancer Res; 2006 Mar 15; 66(6):2913-7. PubMed ID: 16540637 [Abstract] [Full Text] [Related]
29. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features. Ioachim E. Int J Clin Pract; 2008 Nov 15; 62(11):1736-43. PubMed ID: 19143860 [Abstract] [Full Text] [Related]
30. Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides. Weerasinghe P, Garcia GE, Zhu Q, Yuan P, Feng L, Mao L, Jing N. Int J Oncol; 2007 Jul 15; 31(1):129-36. PubMed ID: 17549413 [Abstract] [Full Text] [Related]
31. mTOR signaling pathway is a target for the treatment of colorectal cancer. Zhang YJ, Dai Q, Sun DF, Xiong H, Tian XQ, Gao FH, Xu MH, Chen GQ, Han ZG, Fang JY. Ann Surg Oncol; 2009 Sep 15; 16(9):2617-28. PubMed ID: 19517193 [Abstract] [Full Text] [Related]
32. [Abnormal expression of fragile histidine triad (FHIT) and Mut S homolog 2 (MSH2) proteins in human sporadic colorectal carcinoma and their clinical significance]. Yao CC, Lin CY, Hu MB. Ai Zheng; 2004 Mar 15; 23(3):310-6. PubMed ID: 15025965 [Abstract] [Full Text] [Related]
33. Activation of STAT3 is a marker of poor prognosis in human colorectal cancer. Kusaba T, Nakayama T, Yamazumi K, Yakata Y, Yoshizaki A, Inoue K, Nagayasu T, Sekine I. Oncol Rep; 2006 Jun 15; 15(6):1445-51. PubMed ID: 16685378 [Abstract] [Full Text] [Related]
35. Aberrant Stat3 signaling by interleukin-4 in malignant glioma cells: involvement of IL-13Ralpha2. Rahaman SO, Vogelbaum MA, Haque SJ. Cancer Res; 2005 Apr 01; 65(7):2956-63. PubMed ID: 15805299 [Abstract] [Full Text] [Related]
36. STAT proteins: novel molecular targets for cancer drug discovery. Turkson J, Jove R. Oncogene; 2000 Dec 27; 19(56):6613-26. PubMed ID: 11426647 [Abstract] [Full Text] [Related]
37. Genomic profiling of acquired resistance to apoptosis in cells derived from human atherosclerotic lesions: potential role of STATs, cyclinD1, BAD, and Bcl-XL. Gagarin D, Yang Z, Butler J, Wimmer M, Du B, Cahan P, McCaffrey TA. J Mol Cell Cardiol; 2005 Sep 27; 39(3):453-65. PubMed ID: 16005468 [Abstract] [Full Text] [Related]
38. High Pin1 expression is associated with tumor progression in colorectal cancer. Kuramochi J, Arai T, Ikeda S, Kumagai J, Uetake H, Sugihara K. J Surg Oncol; 2006 Aug 01; 94(2):155-60. PubMed ID: 16847925 [Abstract] [Full Text] [Related]
39. STAT3-decoy oligodeoxynucleotide inhibits the growth of human lung cancer via down-regulating its target genes. Zhang X, Zhang J, Wei H, Tian Z. Oncol Rep; 2007 Jun 01; 17(6):1377-82. PubMed ID: 17487394 [Abstract] [Full Text] [Related]
40. Delineating an oncostatin M-activated STAT3 signaling pathway that coordinates the expression of genes involved in cell cycle regulation and extracellular matrix deposition of MCF-7 cells. Zhang F, Li C, Halfter H, Liu J. Oncogene; 2003 Feb 13; 22(6):894-905. PubMed ID: 12584569 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]